O'Neil R Mason1, Brian P Davidson1, Paul Sheeran2, Matthew Muller1, James M Hodovan1, Jonathan Sutton3, Jeffry Powers2, Jonathan R Lindner4. 1. Knight Cardiovascular Institute, Portland, Oregon. 2. Philips Ultrasound, Bothell, Washington; and Philips Research, Cambridge, Massachusetts. 3. Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon. 4. Knight Cardiovascular Institute, Portland, Oregon; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon. Electronic address: lindnerj@ohsu.edu.
Abstract
OBJECTIVES: The authors investigated ideal acoustic conditions on a clinical scanner custom-programmed for ultrasound (US) cavitation-mediated flow augmentation in preclinical models. We then applied these conditions in a first-in-human study to test the hypothesis that contrast US can increase limb perfusion in normal subjects and patients with peripheral artery disease (PAD). BACKGROUND: US-induced cavitation of microbubble contrast agents augments tissue perfusion by convective shear and secondary purinergic signaling that mediates release of endogenous vasodilators. METHODS: In mice, unilateral exposure of the proximal hindlimb to therapeutic US (1.3 MHz, mechanical index 1.3) was performed for 10 min after intravenous injection of lipid microbubbles. US varied according to line density (17, 37, 65 lines) and pulse duration. Microvascular perfusion was evaluated by US perfusion imaging, and in vivo adenosine triphosphate (ATP) release was assessed using in vivo optical imaging. Optimal parameters were then used in healthy volunteers and patients with PAD where calf US alone or in combination with intravenous microbubble contrast infusion was performed for 10 min. RESULTS: In mice, flow was augmented in the US-exposed limb for all acoustic conditions. Only at the lowest line density was there a stepwise increase in perfusion for longer (40-cycle) versus shorter (5-cycle) pulse duration. For higher line densities, blood flow consistently increased by 3-fold to 4-fold in the US-exposed limb irrespective of pulse duration. High line density and long pulse duration resulted in the greatest release of ATP in the cavitation zone. Application of these optimized conditions in humans together with intravenous contrast increased calf muscle blood flow by >2-fold in both healthy subjects and patients with PAD, whereas US alone had no effect. CONCLUSIONS: US of microbubbles when using optimized acoustic environments can increase perfusion in limb skeletal muscle, raising the possibility of a therapy for patients with PAD. (Augmentation of Limb Perfusion With Contrast Ultrasound; NCT03195556).
OBJECTIVES: The authors investigated ideal acoustic conditions on a clinical scanner custom-programmed for ultrasound (US) cavitation-mediated flow augmentation in preclinical models. We then applied these conditions in a first-in-human study to test the hypothesis that contrast US can increase limb perfusion in normal subjects and patients with peripheral artery disease (PAD). BACKGROUND: US-induced cavitation of microbubble contrast agents augments tissue perfusion by convective shear and secondary purinergic signaling that mediates release of endogenous vasodilators. METHODS: In mice, unilateral exposure of the proximal hindlimb to therapeutic US (1.3 MHz, mechanical index 1.3) was performed for 10 min after intravenous injection of lipid microbubbles. US varied according to line density (17, 37, 65 lines) and pulse duration. Microvascular perfusion was evaluated by US perfusion imaging, and in vivo adenosine triphosphate (ATP) release was assessed using in vivo optical imaging. Optimal parameters were then used in healthy volunteers and patients with PAD where calf US alone or in combination with intravenous microbubble contrast infusion was performed for 10 min. RESULTS: In mice, flow was augmented in the US-exposed limb for all acoustic conditions. Only at the lowest line density was there a stepwise increase in perfusion for longer (40-cycle) versus shorter (5-cycle) pulse duration. For higher line densities, blood flow consistently increased by 3-fold to 4-fold in the US-exposed limb irrespective of pulse duration. High line density and long pulse duration resulted in the greatest release of ATP in the cavitation zone. Application of these optimized conditions in humans together with intravenous contrast increased calf muscle blood flow by >2-fold in both healthy subjects and patients with PAD, whereas US alone had no effect. CONCLUSIONS: US of microbubbles when using optimized acoustic environments can increase perfusion in limb skeletal muscle, raising the possibility of a therapy for patients with PAD. (Augmentation of Limb Perfusion With Contrast Ultrasound; NCT03195556).
Authors: Wen-Shiang Chen; Andrew A Brayman; Thomas J Matula; Lawrence A Crum; Morton W Miller Journal: Ultrasound Med Biol Date: 2003-05 Impact factor: 2.998
Authors: J Todd Belcik; Brian H Mott; Aris Xie; Yan Zhao; Sajeevani Kim; Nathan J Lindner; Azzdine Ammi; Joel M Linden; Jonathan R Lindner Journal: Circ Cardiovasc Imaging Date: 2015-04 Impact factor: 7.792
Authors: Azzdine Y Ammi; Jonathan R Lindner; Yan Zhao; Thomas Porter; Robert Siegel; Sanjiv Kaul Journal: Thromb Haemost Date: 2015-03-26 Impact factor: 5.249
Authors: Feng Xie; Jeroen Slikkerveer; Shunji Gao; John Lof; Otto Kamp; Evan Unger; Stanley Radio; Terry Matsunaga; Thomas R Porter Journal: J Am Soc Echocardiogr Date: 2011-10-29 Impact factor: 5.251
Authors: Thomas R Porter; Stanley Radio; John Lof; Carr Everbach; Jeffry E Powers; Francois Vignon; William T Shi; Feng Xie Journal: Ultrasound Med Biol Date: 2016-04-12 Impact factor: 2.998
Authors: John J Pacella; Judith Brands; Frederick G Schnatz; John J Black; Xucai Chen; Flordeliza S Villanueva Journal: Ultrasound Med Biol Date: 2014-12-23 Impact factor: 2.998
Authors: J Todd Belcik; Brian P Davidson; Aris Xie; Melinda D Wu; Mrinal Yadava; Yue Qi; Sherry Liang; Chae Ryung Chon; Azzdine Y Ammi; Joshua Field; Leanne Harmann; William M Chilian; Joel Linden; Jonathan R Lindner Journal: Circulation Date: 2017-02-07 Impact factor: 29.690
Authors: Matthew A Muller; Koya Ozawa; James Hodovan; Matthew W Hagen; David S H Giraud; Yue Qi; Aris Xie; Theodore R Hobbs; Paul S Sheeran; Jonathan R Lindner Journal: Ultrasound Med Biol Date: 2021-04-29 Impact factor: 3.694
Authors: Matthew A Muller; Todd Belcik; James Hodovan; Koya Ozawa; Eran Brown; Jeffry Powers; Paul S Sheeran; Jonathan R Lindner Journal: J Am Soc Echocardiogr Date: 2021-03-10 Impact factor: 7.722
Authors: Federico Moccetti; Todd Belcik; Yllka Latifi; Aris Xie; Koya Ozawa; Eran Brown; Brian P Davidson; William Packwood; Azzdine Ammi; Sabine Huke; Jonathan R Lindner Journal: J Am Soc Echocardiogr Date: 2020-06-10 Impact factor: 5.251